Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial (Q41235157)

From Wikidata
Jump to navigation Jump to search
scientific article published on 10 March 2015
edit
Language Label Description Also known as
English
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
scientific article published on 10 March 2015

    Statements

    Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial (English)
    0 references
    0 references
    Ronit M Pressler
    Linda S de Vries
    Vincent Jullien
    Brendan Murphy
    Deirdre Murray
    Sampsa Vanhatalo
    NEonatal seizure treatment with Medication Off-patent (NEMO) consortium

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit